(JBL) Jabil Circuit - Overview
Sector: TechnologyIndustry: Electronic Components | Exchange NYSE (USA) | Currency USD | Market Cap: 30.257m | Total Return 87.6% in 12m
Stock: Electronic Hardware, Manufacturing, Design, Supply Chain, Assemblies
Total Rating 70
Risk 74
Buy Signal 0.34
| Risk 5d forecast | |
|---|---|
| Volatility | 46.6% |
| Relative Tail Risk | -22.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 64.54 |
| Character TTM | |
|---|---|
| Beta | 1.519 |
| Beta Downside | 1.509 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.83% |
| CAGR/Max DD | 1.21 |
EPS (Earnings per Share)
Revenue
Description: JBL Jabil Circuit March 05, 2026
Jabil Inc. provides engineering, manufacturing, and supply chain solutions globally. This business model, common in the Electronic Manufacturing Services (EMS) sector, involves producing components and finished goods for other companies.
The company operates across three segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. These segments encompass a wide range of services, including electronic hardware and embedded software design, mechanical design, and advanced optical solutions.
Jabil also offers specialized products like cloud data center server platforms, medical devices, and automotive assemblies. Their services extend to systems assembly, testing, and fulfillment, serving diverse industries such as 5G, healthcare, and automotive. Further research on ValueRay can provide more in-depth analysis of Jabils financial performance and market position.
Headlines to watch out for
- Global supply chain disruptions increase manufacturing costs
- Demand for 5G infrastructure drives revenue growth
- Healthcare device manufacturing expands regulated industries segment
- Automotive sector demand impacts electronics assembly volume
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 809.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.06 > 1.0 |
| NWC/Revenue: 0.61% < 20% (prev 1.09%; Δ -0.48% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.73b > Net Income 809.0m |
| Net Debt (2.56b) to EBITDA (1.97b): 1.30 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (107.6m) vs 12m ago -3.15% < -2% |
| Gross Margin: 9.04% > 18% (prev 0.09%; Δ 894.7% > 0.5%) |
| Asset Turnover: 171.8% > 50% (prev 157.8%; Δ 14.02% > 0%) |
| Interest Coverage Ratio: 4.08 > 6 (EBITDA TTM 1.97b / Interest Expense TTM 306.0m) |
Altman Z'' 1.93
| A: 0.01 (Total Current Assets 15.01b - Total Current Liabilities 14.81b) / Total Assets 20.63b |
| B: 0.33 (Retained Earnings 6.73b / Total Assets 20.63b) |
| C: 0.07 (EBIT TTM 1.25b / Avg Total Assets 19.01b) |
| D: 0.35 (Book Value of Equity 6.73b / Total Liabilities 19.28b) |
| Altman-Z'' Score: 1.93 = BBB |
Beneish M -2.78
| DSRI: 1.00 (Receivables 5.66b/4.77b, Revenue 32.67b/27.45b) |
| GMI: 0.99 (GM 9.04% / 8.94%) |
| AQI: 1.29 (AQ_t 0.11 / AQ_t-1 0.09) |
| SGI: 1.19 (Revenue 32.67b / 27.45b) |
| TATA: -0.04 (NI 809.0m - CFO 1.73b) / TA 20.63b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of JBL shares?
As of March 29, 2026, the stock is trading at USD 261.10 with a total of 891,257 shares traded.
Over the past week, the price has changed by +2.95%, over one month by -1.47%, over three months by +11.16% and over the past year by +87.59%.
Over the past week, the price has changed by +2.95%, over one month by -1.47%, over three months by +11.16% and over the past year by +87.59%.
Is JBL a buy, sell or hold?
Jabil Circuit has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy JBL.
- StrongBuy: 2
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JBL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 293.1 | 12.3% |
| Analysts Target Price | 293.1 | 12.3% |
JBL Fundamental Data Overview March 27, 2026
P/E Trailing = 38.1725
P/E Forward = 20.6186
P/S = 0.9262
P/B = 19.9272
P/EG = 0.8189
Revenue TTM = 32.67b USD
EBIT TTM = 1.25b USD
EBITDA TTM = 1.97b USD
Long Term Debt = 2.39b USD (from longTermDebt, last fiscal year)
Short Term Debt = 599.0m USD (from shortTermDebt, last quarter)
Debt = 4.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.56b USD (from netDebt column, last quarter)
Enterprise Value = 32.82b USD (30.26b + Debt 4.39b - CCE 1.83b)
Interest Coverage Ratio = 4.08 (Ebit TTM 1.25b / Interest Expense TTM 306.0m)
EV/FCF = 22.28x (Enterprise Value 32.82b / FCF TTM 1.47b)
FCF Yield = 4.49% (FCF TTM 1.47b / Enterprise Value 32.82b)
FCF Margin = 4.51% (FCF TTM 1.47b / Revenue TTM 32.67b)
Net Margin = 2.48% (Net Income TTM 809.0m / Revenue TTM 32.67b)
Gross Margin = 9.04% ((Revenue TTM 32.67b - Cost of Revenue TTM 29.71b) / Revenue TTM)
Gross Margin QoQ = 9.01% (prev 8.93%)
Tobins Q-Ratio = 1.59 (Enterprise Value 32.82b / Total Assets 20.63b)
Interest Expense / Debt = 1.69% (Interest Expense 74.0m / Debt 4.39b)
Taxrate = 26.0% (78.0m / 300.0m)
NOPAT = 923.5m (EBIT 1.25b * (1 - 26.00%))
Current Ratio = 1.01 (Total Current Assets 15.01b / Total Current Liabilities 14.81b)
Debt / Equity = 3.27 (Debt 4.39b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 1.30 (Net Debt 2.56b / EBITDA 1.97b)
Debt / FCF = 1.74 (Net Debt 2.56b / FCF TTM 1.47b)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.26% (Net Income 809.0m / Total Assets 20.63b)
RoE = 58.99% (Net Income TTM 809.0m / Total Stockholder Equity 1.37b)
RoCE = 33.21% (EBIT 1.25b / Capital Employed (Equity 1.37b + L.T.Debt 2.39b))
RoIC = 21.65% (NOPAT 923.5m / Invested Capital 4.27b)
WACC = 10.04% (E(30.26b)/V(34.65b) * Re(11.32%) + D(4.39b)/V(34.65b) * Rd(1.69%) * (1-Tc(0.26)))
Discount Rate = 11.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.85%
[DCF] Terminal Value 75.22% ; FCFF base≈1.39b ; Y1≈1.71b ; Y5≈2.92b
[DCF] Fair Price = 308.3 (EV 35.12b - Net Debt 2.56b = Equity 32.56b / Shares 105.6m; r=10.04% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 0.38 | EPS CAGR: 12.67% | SUE: 1.56 | # QB: 4
Revenue Correlation: -39.78 | Revenue CAGR: -0.15% | SUE: 1.91 | # QB: 1
EPS next Quarter (2026-05-31): EPS=3.10 | Chg7d=+0.195 | Chg30d=+0.190 | Revisions Net=+7 | Analysts=9
EPS current Year (2026-08-31): EPS=12.35 | Chg7d=+0.717 | Chg30d=+0.750 | Revisions Net=+8 | Growth EPS=+26.7% | Growth Revenue=+14.8%
EPS next Year (2027-08-31): EPS=14.57 | Chg7d=+1.058 | Chg30d=+1.080 | Revisions Net=+8 | Growth EPS=+17.9% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 11.3% - Earnings Yield 2.6%)
[Growth] Growth Spread = +1.2% (Analyst 9.9% - Implied 8.7%)
P/E Forward = 20.6186
P/S = 0.9262
P/B = 19.9272
P/EG = 0.8189
Revenue TTM = 32.67b USD
EBIT TTM = 1.25b USD
EBITDA TTM = 1.97b USD
Long Term Debt = 2.39b USD (from longTermDebt, last fiscal year)
Short Term Debt = 599.0m USD (from shortTermDebt, last quarter)
Debt = 4.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.56b USD (from netDebt column, last quarter)
Enterprise Value = 32.82b USD (30.26b + Debt 4.39b - CCE 1.83b)
Interest Coverage Ratio = 4.08 (Ebit TTM 1.25b / Interest Expense TTM 306.0m)
EV/FCF = 22.28x (Enterprise Value 32.82b / FCF TTM 1.47b)
FCF Yield = 4.49% (FCF TTM 1.47b / Enterprise Value 32.82b)
FCF Margin = 4.51% (FCF TTM 1.47b / Revenue TTM 32.67b)
Net Margin = 2.48% (Net Income TTM 809.0m / Revenue TTM 32.67b)
Gross Margin = 9.04% ((Revenue TTM 32.67b - Cost of Revenue TTM 29.71b) / Revenue TTM)
Gross Margin QoQ = 9.01% (prev 8.93%)
Tobins Q-Ratio = 1.59 (Enterprise Value 32.82b / Total Assets 20.63b)
Interest Expense / Debt = 1.69% (Interest Expense 74.0m / Debt 4.39b)
Taxrate = 26.0% (78.0m / 300.0m)
NOPAT = 923.5m (EBIT 1.25b * (1 - 26.00%))
Current Ratio = 1.01 (Total Current Assets 15.01b / Total Current Liabilities 14.81b)
Debt / Equity = 3.27 (Debt 4.39b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 1.30 (Net Debt 2.56b / EBITDA 1.97b)
Debt / FCF = 1.74 (Net Debt 2.56b / FCF TTM 1.47b)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.26% (Net Income 809.0m / Total Assets 20.63b)
RoE = 58.99% (Net Income TTM 809.0m / Total Stockholder Equity 1.37b)
RoCE = 33.21% (EBIT 1.25b / Capital Employed (Equity 1.37b + L.T.Debt 2.39b))
RoIC = 21.65% (NOPAT 923.5m / Invested Capital 4.27b)
WACC = 10.04% (E(30.26b)/V(34.65b) * Re(11.32%) + D(4.39b)/V(34.65b) * Rd(1.69%) * (1-Tc(0.26)))
Discount Rate = 11.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.85%
[DCF] Terminal Value 75.22% ; FCFF base≈1.39b ; Y1≈1.71b ; Y5≈2.92b
[DCF] Fair Price = 308.3 (EV 35.12b - Net Debt 2.56b = Equity 32.56b / Shares 105.6m; r=10.04% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 0.38 | EPS CAGR: 12.67% | SUE: 1.56 | # QB: 4
Revenue Correlation: -39.78 | Revenue CAGR: -0.15% | SUE: 1.91 | # QB: 1
EPS next Quarter (2026-05-31): EPS=3.10 | Chg7d=+0.195 | Chg30d=+0.190 | Revisions Net=+7 | Analysts=9
EPS current Year (2026-08-31): EPS=12.35 | Chg7d=+0.717 | Chg30d=+0.750 | Revisions Net=+8 | Growth EPS=+26.7% | Growth Revenue=+14.8%
EPS next Year (2027-08-31): EPS=14.57 | Chg7d=+1.058 | Chg30d=+1.080 | Revisions Net=+8 | Growth EPS=+17.9% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 11.3% - Earnings Yield 2.6%)
[Growth] Growth Spread = +1.2% (Analyst 9.9% - Implied 8.7%)